Stephens Reiterates Overweight Rating for Addus HomeCare (NASDAQ:ADUS)

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “overweight” rating restated by investment analysts at Stephens in a research note issued on Wednesday, Marketbeat reports. They presently have a $142.00 price objective on the stock. Stephens’ price objective indicates a potential upside of 56.42% from the company’s current price.

A number of other research firms also recently commented on ADUS. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Macquarie reissued an “outperform” rating and set a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Finally, Oppenheimer boosted their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $132.78.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $90.78 on Wednesday. The company has a market cap of $1.65 billion, a PE ratio of 20.77, a P/E/G ratio of 1.41 and a beta of 0.97. The company has a fifty day moving average price of $116.65 and a two-hundred day moving average price of $123.82. Addus HomeCare has a 12 month low of $87.88 and a 12 month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Equities research analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Activity at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Summit Place Financial Advisors LLC raised its position in Addus HomeCare by 0.9% in the fourth quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company’s stock worth $1,180,000 after acquiring an additional 80 shares in the last quarter. Janney Montgomery Scott LLC increased its stake in Addus HomeCare by 0.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company’s stock worth $1,340,000 after purchasing an additional 91 shares in the last quarter. Alliancebernstein L.P. increased its stake in Addus HomeCare by 0.5% in the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company’s stock worth $2,465,000 after purchasing an additional 91 shares in the last quarter. Royce & Associates LP increased its stake in Addus HomeCare by 1.2% in the 3rd quarter. Royce & Associates LP now owns 8,924 shares of the company’s stock worth $1,187,000 after purchasing an additional 109 shares in the last quarter. Finally, Assetmark Inc. increased its stake in Addus HomeCare by 11.5% in the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock worth $156,000 after purchasing an additional 121 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.